WS
AGTC

Wedbush Securities’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Wedbush Securities’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-71,490
Closed -$323K – 1034
2019
Q4 		$323K Sell
71,490
-1,500
-2% -$4.74K 0.03% 643
2019
Q3 		$304K Buy
+72,990
New +$264K 0.03% 633
2018
Q2 		– Sell
-10,190
Closed -$39K – 918
2018
Q1 		$39K Buy
+10,190
New +$42.8K 0.01% 794
2017
Q4 		– Sell
-10,190
Closed -$40K – 915
2017
Q3 		$40K Buy
+10,190
New +$46.8K 0.01% 810

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wedbush Securities's AGTC Position: Q1 2020 in Review

Wedbush Securities sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2020, closing a stake of 71,490 shares — an estimated $323K sold.

Wedbush Securities first reported a position in AGTC in Q3 2017 and held it in 4 quarters. The position peaked at $323K in Q4 2019. 59 funds tracked by Wall St. Rank hold AGTC as of Q1 2020.

  • Wedbush Securities reported no remaining Applied Genetic Technologies Corporation position as of Q1 2020 after selling out during the quarter.
  • Wedbush Securities sold 71,490 Applied Genetic Technologies Corporation shares in Q1 2020, an estimated $323K.
  • Wedbush Securities first reported a position in Applied Genetic Technologies Corporation in Q3 2017 and held it in 4 quarters.
  • Wedbush Securities's Applied Genetic Technologies Corporation position peaked at $323K in Q4 2019.
  • 59 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2020.

Based on Wedbush Securities's 13F filing for Q1 2020, filed 17 Apr 2020.